We are live on ! Find out more
CSS

Cubist Systematic Strategies Portfolio holdings

AUM $21B
1-Year Est. Return 21.48%
This Fund
S&P 500
This Quarter Est. Return
-3.05%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$17.8B
AUM Growth
+$1.43B
Cap. Flow
+$2.47B
Cap. Flow %
13.89%
Top 10 Hldgs %
2.97%
Holding
5,084
New
749
Increased
1,923
Reduced
1,590
Closed
686

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$70.4M
2
CHTR icon
Charter Communications
CHTR
+$62M
3
COST icon
Costco
COST
+$48.5M
4
CME icon
CME Group
CME
+$44.7M
5
KO icon
Coca-Cola
KO
+$36.8M

Top Sells

Rank Stock Value
1
BAC icon
Bank of America
BAC
+$55.4M
2
NFLX icon
Netflix
NFLX
+$48.9M
3
ADM icon
Archer Daniels Midland
ADM
+$41.4M
4
WDAY icon
Workday
WDAY
+$40.1M
5
NXPI icon
NXP Semiconductors
NXPI
+$39.4M

Sector Composition

Rank Sector Weight
1 Financials 14.69%
2 Technology 13.52%
3 Healthcare 9.74%
4 Consumer Discretionary 8.75%
5 Industrials 8.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SOAR.WS
4151
DELISTED
Volato Group, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
SOAR.WS
$43K ﹤0.01%
589,696
– –
PXD
4152
CALL
DELISTED
Pioneer Natural Resource Co.
PXD
$43K ﹤0.01%
200
– –
VMCAW
4153
DELISTED
Valuence Merger Corp. I Warrant
VMCAW
$42K ﹤0.01%
267,110
– –
EVE.WS
4154
DELISTED
EVe Mobility Acquisition Corp Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
EVE.WS
$42K ﹤0.01%
424,496
– –
JNCE
4155
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$42K ﹤0.01%
18,000
-2,975
-14% -$10.5K
AVYA
4156
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
$42K ﹤0.01%
26,151
-72,838
-74% -$116K
FHN icon
4157
First Horizon
FHN
$12B
$39K ﹤0.01%
+1,708
New +$38.8K
HIPO icon
4158
Hippo Holdings
HIPO
$856M
$39K ﹤0.01%
2,080
+2,028
+3,900% +$44.8K
HAIAW
4159
DELISTED
Healthcare AI Acquisition Corp. Warrants
HAIAW
$39K ﹤0.01%
307,317
-167,734
-35% -$28.8K
CRNX icon
4160
Crinetics Pharmaceuticals
CRNX
$8.93B
$38K ﹤0.01%
1,925
-6,553
-77% -$134K
FAX
4161
abrdn Asia-Pacific Income Fund
FAX
$604M
$38K ﹤0.01%
+2,517
New +$41.9K
TNGX icon
4162
Tango Therapeutics
TNGX
$4.51B
$38K ﹤0.01%
10,594
-60,295
-85% -$257K
ALORW
4163
DELISTED
ALSP Orchid Acquisition Corp I Warrant
ALORW
$38K ﹤0.01%
422,625
– –
ADV icon
4164
Advantage Solutions
ADV
$383M
$37K ﹤0.01%
+698
New +$64.3K
ATER icon
4165
Aterian
ATER
$5.22M
$37K ﹤0.01%
2,475
-16,354
-87% -$476K
GAN
4166
DELISTED
GAN Ltd
GAN
$37K ﹤0.01%
16,478
-31,404
-66% -$95.3K
SGHT icon
4167
Sight Sciences
SGHT
$424M
$37K ﹤0.01%
+5,802
New +$49.1K
CHAA
4168
DELISTED
Catcha Investment Corp
CHAA
$37K ﹤0.01%
3,700
+1,435
+63% +$14.2K
ITW icon
4169
CALL
Illinois Tool Works
ITW
$83.9B
$36K ﹤0.01%
200
-1,900
-90% -$375K
PRI icon
4170
Primerica
PRI
$9.65B
$36K ﹤0.01%
288
-13,330
-98% -$1.69M
Y
4171
DELISTED
Alleghany Corp
Y
$36K ﹤0.01%
43
-1,172
-96% -$983K
BRCC icon
4172
BRC Inc
BRCC
$216M
$35K ﹤0.01%
4,512
-48,183
-91% -$436K
USBC
4173
USBC Inc
USBC
$137M
$35K ﹤0.01%
+479
New +$37K
BHACW
4174
DELISTED
Focus Impact BH3 Acquisition Company Warrants
BHACW
$35K ﹤0.01%
234,454
-2,535
-1% -$385
TCOA.WS
4175
DELISTED
Zalatoris Acquisition Corp. Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
TCOA.WS
$35K ﹤0.01%
346,120
– –
165 166
167
168 169

Similar funds

GIM
Glenmede Investment Management Philadelphia, Pennsylvania $20.7B AUM
ECM
Eisler Capital Management London, United Kingdom $22.6B AUM 9.36% 1-Year Est. Return
JFL
Jarislowsky, Fraser Ltd Montreal, Quebec, Canada $18.2B AUM 22.04% 1-Year Est. Return
BAM
Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return
SF
Synovus Financial Columbus, Georgia $8.74B AUM 12.78% 1-Year Est. Return
WIM
Waverton Investment Management London, United Kingdom $7.77B AUM 25.07% 1-Year Est. Return
AIM
AXA Investment Managers Puteaux, France $37.1B AUM
SIG
Stonegate Investment Group Birmingham, Alabama $4.31B AUM 18.07% 1-Year Est. Return

Cubist Systematic Strategies's Q3 2022 Portfolio in Review

As of Q3 2022, Cubist Systematic Strategies held 5,084 positions worth $17.8B, up 8.8% from $16.4B the previous quarter. Its ten largest holdings account for 3% of the portfolio.

Cubist Systematic Strategies deployed $2.47B of net new capital in Q3 2022, opening 749 new positions and adding to 1,923 existing holdings. Its largest new stake was Global Blockchain Acquisition Corp. Common Stock: 845,248 shares worth $8.34M.

By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 15% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Bank of America, an estimated $55.4M trimmed.

  • Cubist Systematic Strategies's largest Q3 2022 buy was Global Blockchain Acquisition Corp. Common Stock: 845,248 shares worth $8.34M.
  • Cubist Systematic Strategies added most to Visa in Q3 2022, an estimated $70.4M increase.
  • Cubist Systematic Strategies's biggest Q3 2022 reduction was Bank of America, cutting an estimated $55.4M.
  • Cubist Systematic Strategies fully exited Bristol-Myers Squibb in Q3 2022, selling an estimated $24.2M.
  • Cubist Systematic Strategies's ten largest holdings make up 3% of its $17.8B portfolio in Q3 2022.
  • Cubist Systematic Strategies opened 749 new positions and closed 686 in Q3 2022.
  • Cubist Systematic Strategies's portfolio value rose 8.8% quarter-over-quarter to $17.8B.

Based on Cubist Systematic Strategies's 13F filing for Q3 2022, filed 14 Nov 2022.